Search

everythinglearnresearchcommunity

for

Search:↓

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Analog 23 is a promising compound for prostate cancer treatment.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

A new method was developed to make finasteride for treating hair loss.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Certain compounds reduced hamster flank organ size by inhibiting 5α-reductase, like finasteride, without affecting androgen receptors.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

The compounds tested could potentially treat hair loss and alopecia.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Compound 7p shows strong potential as an anticancer agent.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

The research shows that hydrogen bonds greatly affect the crystal structure of a Finasteride derivative.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Certain Dibenzo derivatives may help treat prostate cancer.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Compound 4 is a promising treatment for hair loss with low toxicity.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

The enzyme system in hair follicles is similar to the liver's and is affected by certain inhibitors.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.